Head-to-head · Cost-Efficiency Index
CoreAge Rx vs HealthOn
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
CoreAge Rx
Anyone optimizing for real value — a transparent flat price you can model for a full year, nationwide, without a bait-and-switch.
Visit CoreAge RxHealthOn
Cost-first shoppers comparing HealthOn's monthly, quarterly, and 12-month compounded GLP-1 tiers side by side.
Visit HealthOnThe verdict
CoreAge Rx takes it, leading the Cost-Efficiency Index 94 to 57. Best value in the ranking: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser. HealthOn still earns a C — Cost-first shoppers comparing HealthOn's monthly, quarterly, and 12-month compounded GLP-1 tiers side by side.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | CoreAge Rx | HealthOn |
|---|---|---|
| Cost-Efficiency Index | 94/100 | 57/100 |
| Semaglutide / mo | $99/mo | $189/mo (1.5 mg dose, compounded) |
| Tirzepatide / mo | $149/mo | $295/mo (10 mg dose, compounded) |
| Semaglutide / yr (modeled) | $1,188 | $2,268 |
| Tirzepatide / yr (modeled) | $1,788 | $3,540 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #1 | #297 |
CoreAge Rx
94/100Where the value is
- Flat all-in monthly price — no intro rate that silently triples after month one, so the modeled annual cost is the real cost
- Both compounded semaglutide and tirzepatide on one account at published prices
- Available in all 50 states — no coverage gamble
The tradeoffs
- Not the rock-bottom sticker price — 30 of the 381 priced semaglutide programs we track list a cheaper figure, though most attach a term or a step-up that CoreAge does not
- No FDA-approved brand-name option (compounded only)
HealthOn
57/100Where the value is
- Both compounded semaglutide ($189/mo) and tirzepatide ($295/mo) are priced on their own dedicated product pages, not gated behind an intake
- Quarterly and 12-month prepay options are disclosed with real dollar savings ($549/quarter and $837/quarter respectively)
- Independent third-party batch testing for potency, sterility, pH, and endotoxins is disclosed as a stated policy
The tradeoffs
- The site's sitewide 'Starting at $155/mo*' nav banner is not specific to either medication and requires a 12-month prepay commitment to actually reach — a shopper skimming only the banner will underestimate the real starting cost by $34-140/mo
- No named prescriber, medical director, or specific compounding pharmacy anywhere on the pages checked
Regulatory note: the FDA issued a warning letter to Healthon Inc. dba Healthon in September 2025. We still list and link to HealthOn; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.